CryoTherapeutics

Belgium
Appelterre-Eichem, Flanders, Belgium, 4431

Company profile

CryoTherapeutics company profile

CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

Business identity

Contact email
[email protected]
Phone number
49 331 2300920
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
4431
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$33.2M
Last funding
Series B / $10.8M / 2024-04-02
Last equity funding
Series B / $10.8M
Investors
10
Lead investors
3
Founders
1
Articles
7

Founders and investors

Founders

Randy Werneth

Lead investors

Creathor VenturesMeusinvest (Noshaq)Peppermint Venture Partners

Investors

Creathor VenturesHTGF (High-Tech Gruenderfonds)KfWMeusinvest (Noshaq)NRW.BANK